Please assess the completion status of the following clinical trial:

Trial Title: Sexual Dysfunction in Gynecologic Oncology Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~* Female~* Age 18-99~* Planned to undergo primary surgical treatment at the University of Iowa Hospitals and Clinics for a suspected or proven diagnosis of ovarian, fallopian tube, peritoneal, endometrial, or cervical cancer~* Able to give informed consent and follow study procedures~* No previous reactions to lidocaine applications~* Performance Status of 0 or 1~* Reports having engaged in vaginal intercourse at least once in the last 12 months~Exclusion criteria:~* Failure to confirm invasive ovarian, fallopian tube, peritoneal, endometrial or cervical cancer by pathology from primary biopsy or surgery (subjects will not be eligible to continue the trial beyond the initial completion of the questionnaires)~* Diagnosis of another malignancy within the past five years, excluding basal cell carcinoma of the skin~* Patients undergoing primary or adjuvant external pelvic radiation (excluding adjuvant vaginal brachytherapy)~* Previous reactions to lidocaine applications~* Previous reactions to lidocaine for the subjects' sexual partner(s)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Patients being treated for gynecologic cancer assigned aqueous lidocaine solution as intervention to use during sexual encounters.
- Placebo (Type: PLACEBO_COMPARATOR): Patients being treated for gynecologic cancer assigned placebo solution as intervention to use during sexual encounters.

Based on this trial design, predict the completion outcome and termination type (if applicable).